cjc-1295 ipamorelin stack benefits side effects dosage Ipamorelin: Benefits, & Risks (2025) CJC-1295/Ipamorelin Injections - Wellness at

This has been shown in a study published in the Journal of Hormone and Metabolic Research , where participants given recombinant human growth hormone showed an increase in IGF-1 levels and decreased abdominal fat after 26 weeks of treatment: Administration of recombinant human growth hormone (rhGH) in obesity has been known to lead to a decrease in visceral adiposity and an increase in lean body mass

Individuals should consult a qualified healthcare professional before beginning any peptide protocol

Ipamorelin is the ONLY ghrelin mimetic that selectively releases growth hormone without significantly elevating cortisol or prolactin

Research suggests that it can stimulate growth hormone release via GHS R1a, allowing researchers to study receptor specificity, endocrine signaling pathways, and peptidereceptor interactions in controlled laboratory models

Sermorelin was FDA-approved in 1997 and sold under the brand name Geref for the treatment of growth hormone deficiency